| Announce Date | 10/01/2025 |
| EPS Normalized Actual | $0.39 (Beat by $0.06) |
| EPS GAAP Actual | $0.39 (Beat by $0.06) |
| Revenue Actual | $2.6326B |
| Revenue Surprise | Beat by $2632.6M |
| Announce Date | 12/31/1969 (Pre-Market) |
| EPS Normalized Estimate | $ |
| EPS GAAP Estimate | $ |
| Revenue Estimate | $0B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| May 2030 | 2.15503 | 7.98 | 2.12188 | 2.21378 | 1 |
| May 2030 | 2.21005 | 7.78 | 2.18846 | 2.25657 | 1 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ3 2025 (Aug 2025) | 0.34 | 0.34 | 2.6326B | -6.17% | 2632.6M |
| FQ2 2025 (May 2025) | 0.54 | 0.54 | 2.7818B | -4.46% | 2781.8M |
| FQ1 2025 (Feb 2025) | 0.3 | 0.3 | 2.841B | -6.75% | 2841M |
| FQ4 2024 (Nov 2024) | 1.57 | 1.57 | 3.1951B | -0.41% | 3195.1M |
| FQ3 2024 (Aug 2024) | 0.98 | 0.98 | 2.7949B | -3.9% | 2794.9M |
| FQ2 2024 (May 2024) | -1.18 | -1.18 | 2.9059B | -2.32% | 2905.9M |
| FQ1 2024 (Feb 2024) | 0.64 | 0.64 | 3.0329B | -1.77% | 3032.9M |
| FQ4 2023 (Nov 2023) | 0.6 | 0.6 | 3.2081B | -3.27% | 3208.1M |
FQ4 Announce Date
12/31/1969 (Pre-Market)
Consensus EPS Estimates
Consensus Revenue Estimates
0B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ2 2028 (May 2028) | 0.52356 | -- | 0.51106 | 0.52927 | 1 |
| FQ1 2028 (Feb 2028) | 0.50016 | -- | 0.48822 | 0.50561 | 1 |
| FQ4 2027 (Nov 2027) | 0.55297 | -- | 0.53977 | 0.559 | 1 |
| FQ3 2027 (Aug 2027) | 0.43693 | -- | 0.4265 | 0.44169 | 1 |
| FQ2 2027 (May 2027) | 0.6518 | -- | 0.64763 | 0.65571 | 3 |
| FQ1 2027 (Feb 2027) | 0.6048 | -- | 0.60234 | 0.60947 | 6 |
| FQ4 2026 (Nov 2026) | 0.73455 | -- | 0.72986 | 0.73895 | 7 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ2 2028 (May 2028) | 2.73B | -- | 2.68B | 2.75B | 4 |
| FQ1 2028 (Feb 2028) | 2.79B | -- | 2.74B | 2.81B | 4 |
| FQ4 2027 (Nov 2027) | 3.06B | -- | 3.01B | 3.09B | 5 |
| FQ3 2027 (Aug 2027) | 2.66B | -- | 2.61B | 2.68B | 5 |
| FQ2 2027 (May 2027) | 2.98B | -- | 2.96B | 2.99B | 3 |
| FQ1 2027 (Feb 2027) | 2.95B | -- | 2.94B | 2.97B | 6 |
| FQ4 2026 (Nov 2026) | 3.27B | -- | 3.26B | 3.29B | 3 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
7
EPS # of Misses
1
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Aug 2025) | 0.34 | 0.34 | 100% | |
| FQ2 2025 (May 2025) | 0.54 | 0.54 | 100% | |
| FQ1 2025 (Feb 2025) | 0.3 | 0.3 | 100% | |
| FQ4 2024 (Nov 2024) | 1.57 | 1.57 | 100% | |
| FQ3 2024 (Aug 2024) | 0.98 | 0.98 | 100% | |
| FQ2 2024 (May 2024) | -1.18 | -1.18 | 100% | |
| FQ1 2024 (Feb 2024) | 0.64 | 0.64 | 100% | |
| FQ4 2023 (Nov 2023) | 0.6 | 0.6 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Aug 2025) | $0B | $2.63B | $2632.6M | 100% |
| FQ2 2025 (May 2025) | $0B | $2.78B | $2781.8M | 100% |
| FQ1 2025 (Feb 2025) | $0B | $2.84B | $2841M | 100% |
| FQ4 2024 (Nov 2024) | $0B | $3.2B | $3195.1M | 100% |
| FQ3 2024 (Aug 2024) | $0B | $2.79B | $2794.9M | 100% |
| FQ2 2024 (May 2024) | $0B | $2.91B | $2905.9M | 100% |
| FQ1 2024 (Feb 2024) | $0B | $3.03B | $3032.9M | 100% |
| FQ4 2023 (Nov 2023) | $0B | $3.21B | $3208.1M | 100% |